You are here

  • Home
  • Online First
  • Postnatal contraception discontinuation: different methods, same problem

Article Text

Article menu

other Versions

Download PDFPDF
Letter to the editor
Postnatal contraception discontinuation: different methods, same problem
  1. Mandisa Singata-Madliki1,
  2. Nolusindiso Dekile-Yonto1,
  3. G J Hofmeyr1,
  4. Theresa A Lawrie1,2
  1. 1 Effective Care Research Unit (ECRU), Eastern Cape Department of Health, East London Hospital Complex, University of Fort Hare, East London, Eastern Cape, South Africa
  2. 2 Cochrane Office, Royal United Hospital, Bath, UK
  1. Correspondence to Mandisa Singata-Madliki, Effective Care Research Unit (ECRU), Eastern Cape Department of Health, East London Hospital Complex, University of Fort Hare, East London, Eastern Cape 5247, South Africa; mandisa.singata{at}gmail.com

https://doi.org/10.1136/bmjsrh-2017-101846

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Following publication of our trial on the effects of postnatal depot medroxyprogesterone acetate (DMPA) compared with the copper intrauterine device (IUD) on postnatal depression in this journal in July 2016,1 we have sought to evaluate contraceptive discontinuation in our study sample. Postnatal contraception is promoted as part of the WHO strategy to reduce the unmet need for family planning in low- and middle-income countries (LMICs) and to reduce preventable maternal and child mortality.2 However, little is known about discontinuation rates associated with postnatal contraception use in these settings.

    From the trial, 75 of 242 participants were contactable two or more years after randomisation and 54 consented to a follow-up interview, which was conducted by a Masters student from the University of Fort Hare (NDY). Twenty-three women had received DMPA and 31 women an IUD. In the DMPA and IUD arms, respectively, 48% (11/23) and 42% …

    View Full Text

    Footnotes

    • Contributors This exploratory study is part of NDYs Masters thesis. NDY wrote the protocol of the exploratory study, collected the data and contributed to interpretation of data. MSM supervised and contributed to interpretation of data and writing of the manuscript. GJH contributed to interpretation of data. TAL contributed to interpretation of data and writing the manuscript. All authors approved the final version.

    • Funding This study was funded by the South African Medical Research Council (SAMRC) under the SAMRC Research Capacity Development Initiative (RCDI) Programme.

    • Competing interests None declared.

    • Ethics approval University of Fort Hare Ethics Committee: Certificate reference no.SIN011SYON01 (17/5/2015).

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Data sharing statement The authors subscribe to data sharing and are willing to make data from this study available on request.